The purpose of this study is to evaluate the comparative effectiveness of two different informatics-enabled implementation strategies on increasing tobacco treatment and improving smoking cessation rates for cancer control and prevention. This will be done via a two-arm pragmatic cluster randomized trial (CRT) to test the effectiveness of nudges to change (ELEVATE-S) vs. quit-focused usual care (ELEVATE) in increasing tobacco treatment (use of medication, brief advice, or referral to external counseling) and smoking cessation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
5,000
ELEVATE uses implementation strategies to support clinicians (support clinicians by revising professional roles to enable point of care tobacco treatment with a team are approach and support clinicians by providing clinical decision support tools).
ELEVATE-S uses implementation strategies to support clinicians (support clinicians by revising professional roles to enable point of care tobacco treatment with a team are approach and support clinicians by providing clinical decision support tools) and implementation strategies to support patients with chronic care model-informed self-management support (patient centered flexible goals and patient-generated health data).
Washington University School of Medicine
St Louis, Missouri, United States
RECRUITINGPatient receipt of tobacco use treatment, i.e. Tobacco use treatment (TUT) Reach
This will be quantified by the proportion of enrolled patients who receive tobacco use treatment (either medication or behavioral intervention (brief advice or referral to counseling)).
Time frame: Up to 6 months post-enrollment
Patient receipt of tobacco use treatment - behavioral intervention.
This will be quantified by the proportion of enrolled patients who receive tobacco use treatment behavioral intervention (brief advice or referral to counseling).
Time frame: Up to 6 months post-enrollment
Patient receipt of tobacco use treatment - medication.
This will be quantified by the proportion of enrolled patients who receive tobacco use treatment medication.
Time frame: Up to 6 months post-enrollment
Patient smoking abstinence
This will be quantified by the proportion of patients who smoke with EHR-documented smoking abstinence
Time frame: Up to 6 months post-enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.